Rezivertinib hydrochloride

SI-7838

Rezivertinib hydrochloride, >98% (HPLC)

CAS No. : [2170255-78-2]

Synonyms : BPI-7711 hydrochloride

IUPAC Name : N-(2-(2-(Dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide hydrochloride

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
250MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
500MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Rezivertinib hydrochloride is an irreversible, orally active third‑generation EGFR inhibitor with high potency against activating EGFR variants and the T790M resistance mutation. Its excellent CNS penetration enhances its therapeutic potential, and it demonstrates significant antitumor effects in NSCLC and related tumor models.

References : Nagasaka M. et al.: J. Thorac. Oncol., 16(5), 740-763, 2021.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.